Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma

Figure 8

Prediction of sensitivity to immunotherapy based on PTPRO expression levels. (a) Correlation analysis of immune checkpoints and PTPRO expression level. (b) Immune, stromal, and ESTIMATE scores for high and low PTPRO expressions in LUAD. (c–f) The IPS scores between high and low expressions of the PTPRO groups when CTLA-4 or/and PD1 positive.

(a)

(b)

(c)

(d)

(e)

(f)